260 related articles for article (PubMed ID: 22019011)
1. RAGE: a single receptor fits multiple ligands.
Fritz G
Trends Biochem Sci; 2011 Dec; 36(12):625-32. PubMed ID: 22019011
[TBL] [Abstract][Full Text] [Related]
2. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
3. RAGE-mediated cell signaling.
Rouhiainen A; Kuja-Panula J; Tumova S; Rauvala H
Methods Mol Biol; 2013; 963():239-63. PubMed ID: 23296615
[TBL] [Abstract][Full Text] [Related]
4. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
[TBL] [Abstract][Full Text] [Related]
5. RAGE regulation and signaling in inflammation and beyond.
Kierdorf K; Fritz G
J Leukoc Biol; 2013 Jul; 94(1):55-68. PubMed ID: 23543766
[TBL] [Abstract][Full Text] [Related]
6. RAGE in inflammation: a new therapeutic target?
Bierhaus A; Stern DM; Nawroth PP
Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
[TBL] [Abstract][Full Text] [Related]
7. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
Ramasamy R; Yan SF; Schmidt AM
J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
Herold K; Moser B; Chen Y; Zeng S; Yan SF; Ramasamy R; Emond J; Clynes R; Schmidt AM
J Leukoc Biol; 2007 Aug; 82(2):204-12. PubMed ID: 17513693
[TBL] [Abstract][Full Text] [Related]
9. Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability.
Kumano-Kuramochi M; Ohnishi-Kameyama M; Xie Q; Niimi S; Kubota F; Komba S; Machida S
Biochem Biophys Res Commun; 2009 Aug; 386(1):130-4. PubMed ID: 19501570
[TBL] [Abstract][Full Text] [Related]
10. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.
Zeng S; Feirt N; Goldstein M; Guarrera J; Ippagunta N; Ekong U; Dun H; Lu Y; Qu W; Schmidt AM; Emond JC
Hepatology; 2004 Feb; 39(2):422-32. PubMed ID: 14767995
[TBL] [Abstract][Full Text] [Related]
11. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
Ramasamy R; Yan SF; Schmidt AM
Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
[TBL] [Abstract][Full Text] [Related]
12. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
[TBL] [Abstract][Full Text] [Related]
13. Rage signalling promotes intestinal tumourigenesis.
Heijmans J; Büller NV; Hoff E; Dihal AA; van der Poll T; van Zoelen MA; Bierhaus A; Biemond I; Hardwick JC; Hommes DW; Muncan V; van den Brink GR
Oncogene; 2013 Feb; 32(9):1202-6. PubMed ID: 22469986
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
15. The immunobiology of the receptor of advanced glycation end-products: trends and challenges.
González I; Romero J; Rodríguez BL; Pérez-Castro R; Rojas A
Immunobiology; 2013 May; 218(5):790-7. PubMed ID: 23182709
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.
Liliensiek B; Weigand MA; Bierhaus A; Nicklas W; Kasper M; Hofer S; Plachky J; Gröne HJ; Kurschus FC; Schmidt AM; Yan SD; Martin E; Schleicher E; Stern DM; Hämmerling G Gü; Nawroth PP; Arnold B
J Clin Invest; 2004 Jun; 113(11):1641-50. PubMed ID: 15173891
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
Christaki E; Lazaridis N; Opal SM
Curr Opin Infect Dis; 2012 Jun; 25(3):304-11. PubMed ID: 22327468
[TBL] [Abstract][Full Text] [Related]
18. RAGE, vascular tone and vascular disease.
Farmer DG; Kennedy S
Pharmacol Ther; 2009 Nov; 124(2):185-94. PubMed ID: 19616578
[TBL] [Abstract][Full Text] [Related]
19. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
Allmen EU; Koch M; Fritz G; Legler DF
Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
[TBL] [Abstract][Full Text] [Related]
20. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?
Basta G; Navarra T; De Simone P; Del Turco S; Gastaldelli A; Filipponi F
Liver Transpl; 2011 Jun; 17(6):633-40. PubMed ID: 21438128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
